Clinical Trial Update: Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether combining mitoxantrone with dexrazoxane reduces cardiac problems in multiple sclerosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Novantrone (mitoxantrone)
• Zinecard (dexrazoxane)

Snippet

Sponsor: PD Dr. Andrew Chan | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN